Four out of 10 people who have lingering health issues after COVID-19 infection can count bothersome sleep problems among them. About 41% of those with so-called long COVID have moderate to severe sleep issues, according to new...

New research suggests that gender and money matter when it comes to getting a last-resort treatment after mechanical ventilation. Funded by the U.S. National Institutes of Health, the study found that certain groups are more likely to...

The U.S. Food and Drug Administration on Thursday formally withdrew its approval of a drug that was meant to prevent preterm births. Sold as Makena, the drug was first approved in 2011 under the FDA’s accelerated approval...

A therapy that arms the immune system to find and destroy tumor cells has shown early promise against a rare and aggressive childhood cancer. Experts called the findings “promising.” But they cautioned that much larger studies are...

Scientists have created an embryo-like structure using monkey embryonic stem cells for the first time, part of an effort to better understand early human development and organ formation. The researchers created the structures in a lab in...

Does it sometimes feel like your young picky eater is turning every meal and snack into an epic power battle — and you’re just not sure how to get them the nutrition they need? If so, you’re...

Elation and exhaustion often go hand in hand when you’re a parent to a baby. When sleep starts to seem like a fantasy, it’s good to know that the experts say there is a time when most...

THURSDAY, April 6, 2023 (American Heart Association News) — Long before she was a nutrition professional, Josiemer Mattei was a girl living in Puerto Rico. “I had the advantage and amazing experience of growing up near a...

Centenarians might live 100 years or more thanks in part to a more agile and adaptive immune system, a new study reveals. Blood tests of seven centenarians — average age 106 — found they possess highly functional...

An RSV vaccine developed by Pfizer provides safe and effective protection in both seniors and newborns, clinical trial results show. The vaccine is 86% effective in protecting older adults against RSV infections severe enough to cause three...